Oncopharmpod
Zolbetuximab
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:19:30
- Mas informaciones
Informações:
Sinopsis
The first Cldn 18.2 targeting monoclonal antibody has been improved. Let's talk about it!
The first Cldn 18.2 targeting monoclonal antibody has been improved. Let's talk about it!
